View in EDS HTML Full Text PDF Full Text

High-Throughput Screening for the Prevalence of Neutralizing Antibodies against Human Adenovirus Serotype 5.

Saved in:
Bibliographic Details
Title: High-Throughput Screening for the Prevalence of Neutralizing Antibodies against Human Adenovirus Serotype 5.
Authors: Wettengel JM; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.; Institute of Virology, Technical University of Munich, 81675 Munich, Germany.; German Center for Infection Research, Munich Partner Site, 81675 Munich, Germany., Naka H; Division of Genetics, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA., Dissen GA; Molecular Virology Core, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA., Torgerson J; Molecular Virology Core, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA., Pounder M; Molecular Virology Core, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA., Mueller SF; LABOKLIN GmbH, 97688 Bad Kissingen, Germany., Mueller E; LABOKLIN GmbH, 97688 Bad Kissingen, Germany., Hagen P; Institute of Virology, Technical University of Munich, 81675 Munich, Germany., Brandt M; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA., Protzer U; Institute of Virology, Technical University of Munich, 81675 Munich, Germany.; German Center for Infection Research, Munich Partner Site, 81675 Munich, Germany., Burwitz BJ; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Source: Vaccines [Vaccines (Basel)] 2024 Feb 01; Vol. 12 (2). Date of Electronic Publication: 2024 Feb 01.
Publication Type: Journal Article
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38400138
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: High-Throughput Screening for the Prevalence of Neutralizing Antibodies against Human Adenovirus Serotype 5.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wettengel+JM%22">Wettengel JM</searchLink>; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.; Institute of Virology, Technical University of Munich, 81675 Munich, Germany.; German Center for Infection Research, Munich Partner Site, 81675 Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Naka+H%22">Naka H</searchLink>; Division of Genetics, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.<br /><searchLink fieldCode="AU" term="%22Dissen+GA%22">Dissen GA</searchLink>; Molecular Virology Core, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.<br /><searchLink fieldCode="AU" term="%22Torgerson+J%22">Torgerson J</searchLink>; Molecular Virology Core, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.<br /><searchLink fieldCode="AU" term="%22Pounder+M%22">Pounder M</searchLink>; Molecular Virology Core, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.<br /><searchLink fieldCode="AU" term="%22Mueller+SF%22">Mueller SF</searchLink>; LABOKLIN GmbH, 97688 Bad Kissingen, Germany.<br /><searchLink fieldCode="AU" term="%22Mueller+E%22">Mueller E</searchLink>; LABOKLIN GmbH, 97688 Bad Kissingen, Germany.<br /><searchLink fieldCode="AU" term="%22Hagen+P%22">Hagen P</searchLink>; Institute of Virology, Technical University of Munich, 81675 Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Brandt+M%22">Brandt M</searchLink>; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.<br /><searchLink fieldCode="AU" term="%22Protzer+U%22">Protzer U</searchLink>; Institute of Virology, Technical University of Munich, 81675 Munich, Germany.; German Center for Infection Research, Munich Partner Site, 81675 Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Burwitz+BJ%22">Burwitz BJ</searchLink>; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101629355%22">Vaccines</searchLink> [Vaccines (Basel)] 2024 Feb 01; Vol. 12 (2). <i>Date of Electronic Publication: </i>2024 Feb 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI+AG%22">MDPI AG </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101629355 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2076-393X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222076393X%22">2076393X </searchLink><i>NLM ISO Abbreviation: </i>Vaccines (Basel) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38400138
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/vaccines12020155
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: High-Throughput Screening for the Prevalence of Neutralizing Antibodies against Human Adenovirus Serotype 5.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wettengel JM
      – PersonEntity:
          Name:
            NameFull: Naka H
      – PersonEntity:
          Name:
            NameFull: Dissen GA
      – PersonEntity:
          Name:
            NameFull: Torgerson J
      – PersonEntity:
          Name:
            NameFull: Pounder M
      – PersonEntity:
          Name:
            NameFull: Mueller SF
      – PersonEntity:
          Name:
            NameFull: Mueller E
      – PersonEntity:
          Name:
            NameFull: Hagen P
      – PersonEntity:
          Name:
            NameFull: Brandt M
      – PersonEntity:
          Name:
            NameFull: Protzer U
      – PersonEntity:
          Name:
            NameFull: Burwitz BJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2024 Feb 01
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 2076-393X
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Vaccines
              Type: main
ResultId 1